0,920  0,001  Pneumotoxic
0,770  0,005  CYP2C19 substrate
0,762  0,021  Antiinflammatory
0,746  0,007  CYP1A2 substrate
0,713  0,029  Apoptosis agonist
0,661  0,008  Cardiovascular analeptic
0,657  0,007  Immunosuppressant
0,581  0,014  Antipruritic, allergic
0,563  0,003  Abortion inducer
0,522  0,008  Sigma receptor agonist
0,528  0,014  Nitric oxide antagonist
0,504  0,010  Sedative
0,476  0,006  Antiacne
0,485  0,024  Carcinogenic
0,506  0,053  Antineoplastic (breast cancer)
0,495  0,061  Caspase 9 stimulant
0,452  0,027  Antimycobacterial
0,434  0,014  Calcium channel activator
0,471  0,055  TNF expression inhibitor
0,415  0,012  5 Hydroxytryptamine uptake stimulant
0,410  0,009  Antipruritic, non-allergic
0,451  0,057  Antibacterial
0,427  0,037  FMO1 substrate
0,393  0,016  UGT1A4 substrate
0,400  0,032  NOS2 expression inhibitor
0,422  0,060  GST A substrate
0,385  0,025  Antineoplastic (osteosarcoma)
0,419  0,061  Antineoplastic (lung cancer)
0,369  0,015  UGT2B7 substrate
0,397  0,060  Ulceration
0,371  0,037  Interleukin 2 agonist
0,335  0,014  Acaricide
0,367  0,050  AR expression inhibitor
0,349  0,033  Antiparasitic
0,357  0,042  Cytotoxic
0,330  0,026  Antihelmintic
0,320  0,017  Prostate disorders treatment
0,359  0,057  Antifungal
0,361  0,061  Antithrombotic
0,388  0,090  Analgesic
0,395  0,098  Alzheimer's disease treatment
0,305  0,010  UGT2B9 substrate
0,311  0,018  Hair growth stimulant
0,326  0,036  Psychostimulant
0,321  0,035  GST M1-1 substrate
0,347  0,063  ICAM1 expression inhibitor
0,323  0,041  Mutagenic
0,301  0,020  Interferon gamma antagonist
0,329  0,050  UGT2B4 substrate
0,309  0,033  Antiparkinsonian, rigidity relieving
0,315  0,041  Interleukin agonist
0,291  0,018  Antiviral (Influenza A)
0,328  0,056  Antihypercholesterolemic
0,349  0,077  Transcription factor NF kappa B inhibitor
0,312  0,045  Angiogenesis stimulant
0,325  0,059  CTGF expression inhibitor
0,333  0,070  Antineoplastic (colorectal cancer)
0,316  0,053  Chemoprotective
0,329  0,066  Antineoplastic (colon cancer)
0,348  0,087  GABA C receptor rho-3 antagonist
0,308  0,050  Proliferative diseases treatment
0,289  0,034  Antihypotensive
0,328  0,074  Cholesterol antagonist
0,332  0,085  CYP3A4 substrate
0,252  0,005  Vanilloid agonist
0,257  0,012  ATPase inhibitor
0,286  0,043  Gastrin inhibitor
0,309  0,067  Antineoplastic (melanoma)
0,249  0,009  Microtubule formation inhibitor
0,308  0,071  Analeptic
0,281  0,044  Tyrosine 3 hydroxylase inhibitor
0,275  0,042  Platelet adhesion inhibitor
0,324  0,092  CYP2C9 substrate
0,295  0,063  Teratogen
0,303  0,072  Antineoplastic (endocrine cancer)
0,240  0,008  Arachidonic acid antagonist
0,288  0,059  Sensitization
0,252  0,025  CNS active muscle relaxant
0,272  0,047  Chemopreventive
0,294  0,071  Antineoplastic (pancreatic cancer)
0,255  0,033  Prostatic (benign) hyperplasia treatment
0,232  0,015  Expectorant
0,312  0,097  Antileukemic
0,255  0,042  Hepatoprotectant
0,227  0,016  GABA C receptor agonist
0,227  0,021  UGT2B10 substrate
0,235  0,030  Protein kinase stimulant
0,279  0,077  5 Hydroxytryptamine release stimulant
0,250  0,049  RNA-directed DNA polymerase inhibitor
0,211  0,011  Mucolytic
0,247  0,048  UGT1A1 substrate
0,266  0,068  Embryotoxic
0,267  0,071  Transcription factor STAT3 inhibitor
0,243  0,049  Antiviral (Influenza)
0,328  0,135  5 Hydroxytryptamine release inhibitor
0,202  0,010  TRPA1 agonist
0,212  0,028  Antifungal enhancer
0,250  0,066  DNA synthesis inhibitor
0,237  0,054  Antialcoholic
0,275  0,093  Caspase 3 stimulant
0,230  0,051  Neurotrophic factor enhancer
0,208  0,030  Antirickettsial
0,193  0,015  Antiinfertility, female
0,247  0,070  Antineoplastic (sarcoma)
0,199  0,021  Antineoplastic antibiotic
0,251  0,074  5 Hydroxytryptamine 1E antagonist
0,269  0,093  Antipsoriatic
0,206  0,032  Carcinogenic, group 1
0,197  0,023  CF transmembrane conductance regulator agonist
0,180  0,007  Anabolic
0,210  0,041  Succinate dehydrogenase inhibitor
0,253  0,085  Transcription factor STAT inhibitor
0,202  0,034  Alpha-N-acetylglucosaminidase inhibitor
0,263  0,095  NOS3 expression inhibitor
0,195  0,028  Antihyperlipoproteinemic
0,259  0,097  Respiratory analeptic
0,168  0,006  5-Alpha-reductase inhibitor
0,179  0,019  Vanilloid 1 agonist
0,186  0,029  Antitussive
0,204  0,050  VEGF expression inhibitor
0,204  0,050  3C-like protease (Human coronavirus) inhibitor
0,212  0,059  CYP2B6 inhibitor
0,288  0,137  CYP2C19 inhibitor
0,166  0,019  Androgen antagonist
0,159  0,018  Actinic keratosis treatment
0,187  0,047  Melanin inhibitor
0,154  0,015  CYP2A6 inhibitor
0,161  0,022  Ca2+-transporting ATPase inhibitor
0,152  0,014  UGT2B11 substrate
0,161  0,024  GABA C receptor antagonist
0,170  0,035  Adenylate cyclase stimulant
0,181  0,047  MAO inhibitor
0,238  0,106  Antiepileptic
0,186  0,054  Phospholipase C inhibitor
0,267  0,137  Calpain 2 inhibitor
0,215  0,087  Cytostatic
0,147  0,019  GST T1-1 substrate
0,153  0,026  Antiviral (Influenza B)
0,165  0,038  Farnesoid X receptor antagonist
0,157  0,032  GABA receptor agonist
0,169  0,048  SULT1A3 substrate
0,129  0,010  Narcotic antagonist
0,155  0,037  Carcinogenic, group 2B
0,313  0,195  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,184  0,067  Lipocortins synthesis antagonist
0,129  0,012  T cell inhibitor
0,214  0,100  Antineoplastic (renal cancer)
0,181  0,068  Muscle relaxant
0,175  0,062  Eye irritation, high
0,199  0,089  VCAM1 expression inhibitor
0,144  0,037  Alcohol dehydrogenase substrate
0,141  0,037  Photosensitizer
0,147  0,046  Protein-tyrosine phosphatase 1B inhibitor
0,147  0,046  Cholesterol synthesis inhibitor
0,166  0,066  Uterine stimulant
0,123  0,023  Ornithine decarboxylase inhibitor
0,143  0,043  MAO A inhibitor
0,118  0,019  Glycine receptor antagonist
0,103  0,004  Pregnane X receptor antagonist
0,144  0,046  Autism spectrum disorders treatment
0,152  0,055  Antifungal (Cryptococcus)
0,165  0,068  Antimutagenic
0,182  0,085  Anesthetic general
0,101  0,005  5-Alpha-reductase 2 inhibitor
0,108  0,012  Vanilloid 4 agonist
0,158  0,061  Antiparkinsonian, tremor relieving
0,122  0,026  Antidote, mercury
0,125  0,029  Antispirochetal
0,136  0,042  Antiviral (Poxvirus)
0,131  0,037  Estrogen antagonist
0,194  0,100  Nitric-oxide synthase stimulant
0,139  0,046  Cystathionine beta-synthase inhibitor
0,132  0,038  UGT2B1 substrate
0,113  0,020  Na+ K+ transporting ATPase inhibitor
0,203  0,111  Calpain inhibitor
0,141  0,050  Skin irritative effect
0,229  0,139  Prostaglandin dehydrogenase inhibitor
0,092  0,003  Tubulin agonist
0,167  0,079  Toxic, respiratory center
0,222  0,135  Bone diseases treatment
0,102  0,014  Androgen agonist
0,114  0,027  GABA A receptor agonist
0,101  0,014  Dopamine D4 agonist
0,119  0,033  Estrogen receptor beta antagonist
0,125  0,039  Antiprotozoal (Toxoplasma)
0,153  0,067  UGT2B15 substrate
0,089  0,005  5-Alpha-reductase 1 inhibitor
0,121  0,038  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,145  0,062  Pregnane X receptor agonist
0,088  0,008  Anesthetic inhalation
0,111  0,031  Interleukin 5 antagonist
0,110  0,030  Antibiotic
0,110  0,030  Inducible nitric-oxide synthase inhibitor
0,215  0,135  Insulysin inhibitor
0,093  0,014  Glutamate (mGluR6) antagonist
0,144  0,066  Contraceptive
0,156  0,079  UGT1A3 substrate
0,198  0,121  Spasmolytic
0,155  0,081  Antihelmintic (Nematodes)
0,084  0,011  Calcium channel P-type blocker
0,183  0,110  Antineoplastic (glioma)
0,099  0,028  Estrogen receptor alpha antagonist
0,199  0,129  UGT1A9 substrate
0,194  0,124  Immunostimulant
0,083  0,013  Aconitate hydratase inhibitor
0,149  0,079  Protein-tyrosine phosphatase inhibitor
0,094  0,025  Glycine receptor agonist
0,133  0,064  Cyclooxygenase 3 inhibitor
0,115  0,047  UDP-glucose 4-epimerase inhibitor
0,091  0,023  Aromatase inhibitor
0,079  0,011  Aldosterone antagonist
0,080  0,013  Postcoital contraceptive
0,119  0,053  Choleretic
0,090  0,024  Antitreponemal
0,085  0,019  SULT2A1 substrate
0,105  0,040  Bile acid receptor antagonist
0,126  0,061  Contraceptive female
0,079  0,014  Lipocortins synthesis agonist
0,177  0,113  5 Hydroxytryptamine 3E antagonist
0,219  0,155  Vasodilator, peripheral
0,089  0,025  Anticholelithogenic
0,192  0,129  Antineoplastic (ovarian cancer)
0,122  0,059  Antifungal (Pneumocystis)
0,159  0,096  Phobic disorders treatment
0,096  0,033  Keratolytic
0,066  0,005  Kainate receptor agonist
0,152  0,092  Antipruritic
0,120  0,060  Shock treatment
0,196  0,137  Flavin-containing monooxygenase substrate
0,095  0,037  Phosphodiesterase 3A inhibitor
0,066  0,009  Microtubule stabilization
0,107  0,052  Antineoplastic, alkylator
0,111  0,056  DOPA decarboxylase inhibitor
0,077  0,023  Hypercalcemia treatment
0,174  0,121  UGT1A6 substrate
0,112  0,060  Ferrochelatase inhibitor
0,114  0,062  SULT1A1 substrate
0,100  0,048  Triose-phosphate isomerase inhibitor
0,117  0,066  Calcium channel N-type blocker
0,157  0,106  UDP-glucuronosyltransferase substrate
0,076  0,025  Antimycoplasmal
0,134  0,084  Skeletal muscle relaxant
0,107  0,057  Antifungal (Aspergillus)
0,092  0,043  Opioid kappa receptor antagonist
0,113  0,064  Mental retardation treatment
0,068  0,019  Dihydroorotate oxidase inhibitor
0,072  0,023  Protein 50S ribosomal subunit inhibitor
0,084  0,036  MAP kinase kinase 7 inhibitor
0,069  0,022  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,063  0,017  Estrogen receptor beta agonist
0,170  0,126  Antiviral (Ebola)
0,045  0,003  Vanilloid 2 agonist
0,162  0,121  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,095  0,054  Antithrombocytopenic
0,092  0,052  ATPase (Vacuolar H+) inhibitor
0,082  0,043  Antidote, organophosphates
0,110  0,071  Aldehyde dehydrogenase substrate
0,058  0,019  Cholesterol esterase inhibitor
0,065  0,026  Ryanodine receptor antagonist
0,202  0,163  FMO3 substrate
0,043  0,005  Nicotinic acid receptor 2 antagonist
0,083  0,045  Porphobilinogen synthase inhibitor
0,039  0,002  4-Hydroxyphenylpyruvate dioxygenase inhibitor
0,053  0,016  Retinoid X receptor agonist
0,094  0,058  GST P1-1 substrate
0,088  0,054  Transcription factor NF kappa B stimulant
0,095  0,061  Prolactin inhibitor
0,047  0,014  Delayed rectifier potassium channel blocker
0,209  0,176  Sodium/bile acid cotransporter inhibitor
0,162  0,129  Aldehyde oxidase inhibitor
0,151  0,119  Antineoplastic (glioblastoma multiforme)
0,109  0,078  Carcinogenic, group 3
0,047  0,016  Retinoid X alpha receptor agonist
0,040  0,010  Glutamate (mGluR3) agonist
0,064  0,034  Argininosuccinate synthase inhibitor
0,069  0,040  Antihemophilic
0,117  0,088  Antihelmintic (Trematoda)
0,047  0,018  Membrane dipeptidase inhibitor
0,092  0,063  Antiviral (Rhinovirus)
0,062  0,034  Alcohol oxidase inhibitor
0,104  0,077  Acetylcholine release stimulant
0,045  0,019  Retinoic acid alpha receptor agonist
0,093  0,067  Creatine kinase inhibitor
0,098  0,072  Adenylate kinase inhibitor
0,130  0,105  GABA C receptor rho-2 antagonist
0,049  0,025  Opioid kappa receptor agonist
0,076  0,052  GABA aminotransferase inhibitor
0,108  0,084  Antiseptic
0,042  0,019  Nicotinic acid receptor agonist
0,032  0,010  Retinoid X gamma receptor antagonist
0,088  0,066  Paget's disease treatment
0,070  0,048  Phosphofructokinase-1 inhibitor
0,038  0,016  Adenosine uptake inhibitor
0,098  0,077  Excitatory amino acid transporter EAAC1 inhibitor
0,046  0,026  Histamine H2 receptor agonist
0,105  0,085  Menstruation disorders treatment
0,041  0,022  Retinoid X receptor antagonist
0,110  0,091  Coagulant
0,085  0,065  NADH dehydrogenase inhibitor
0,041  0,021  Glutamate (mGluR8) agonist
0,156  0,137  Antineoplastic (lymphoma)
0,042  0,023  GABA uptake inhibitor
0,037  0,019  Retinoid X alpha receptor antagonist
0,087  0,069  HIV-1 integrase (Overall Integration) inhibitor
0,024  0,006  Nicotinic acid receptor 1 antagonist
0,053  0,036  Nicotinic alpha3beta2 receptor antagonist
0,024  0,008  Retinoid X beta receptor antagonist
0,027  0,010  GRP78 expression inhibitor
0,048  0,033  Glucose-6-phosphate isomerase inhibitor
0,031  0,016  Purinergic P2Y15 antagonist
0,025  0,010  Retinoic acid gamma receptor agonist
0,121  0,107  Antiprotozoal (Coccidial)
0,039  0,025  Vanilloid 3 antagonist
0,025  0,012  Prostaglandin F2 alpha agonist
0,111  0,099  Cocaine dependence treatment
0,033  0,020  ATP citrate lysase inhibitor
0,024  0,012  Vitamin D receptor antagonist
0,148  0,137  Antiulcerative
0,106  0,095  Anesthetic
0,016  0,004  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,029  0,018  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,025  0,013  Retinoic acid receptor agonist
0,021  0,010  Progesterone receptor B antagonist
0,036  0,025  Nicotinic acid receptor 2 agonist
0,044  0,034  Parathyroid hormone antagonist
0,061  0,051  Interferon inducer
0,151  0,142  Antineoplastic (cervical cancer)
0,024  0,015  Retinoid X gamma receptor agonist
0,091  0,082  Glutamate (mGluR7) agonist
0,013  0,005  Calcineurin inhibitor
0,036  0,028  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,175  0,168  CYP2D6 substrate
0,015  0,010  CC chemokine 10 receptor antagonist
0,155  0,149  Antipyretic
0,040  0,034  Guanylate cyclase inhibitor
0,017  0,012  Telomerase stimulant
0,088  0,082  Tourette's syndrome treatment
0,097  0,092  Proteasome inhibitor
0,072  0,067  Interferon agonist
0,027  0,022  Hedgehog signaling activator
0,018  0,014  Alpha 2b adrenoreceptor agonist
0,077  0,072  Ca(v)3.1 blocker
0,130  0,126  Movement disorders treatment
0,083  0,079  Aminopeptidase B inhibitor
0,085  0,081  Posttraumatic stress disorder treatment
0,019  0,015  Retinoic acid beta receptor agonist
0,065  0,061  Aminopeptidase I inhibitor
0,087  0,083  Nitric-oxide synthase inhibitor
0,138  0,135  Non-steroidal antiinflammatory agent
0,053  0,051  Carbamoyl phosphate synthetase inhibitor
0,057  0,055  Antiviral (Parainfluenza)
0,079  0,077  Granulocyte macrophage colony stimulating factor agonist
0,014  0,013  NMDA receptor phencyclidine site antagonist
0,009  0,008  Progesterone receptor A antagonist
0,019  0,018  Retinoid X beta receptor agonist
0,005  0,005  Transcortin receptor antagonist

